DCT

3:15-cv-06075

Merck Sharp & Dohme Corp v. Actavis Laboratories FL Inc

General

Filed

08/06/15

Cause of ActionPatent Infringement

SectorChemical Biotech

Status

Closed (12/12/17)

Patent Owner

Operating Company (W)

PACER3:15-cv-06075

Appeals18-1422

CourtD. New Jersey

Judge	Period	PO Win Rate
Peter G. Sheridan	--	63%

Plaintiff

Party

Name	Ratings
Merck Sharp & Dohme Corp	L5A
Merck Sharp & Dohme LLC	L5A

Attorney

Name	Ratings
GibbonsLocal	L3B
David E. Delorenzi	L3A
Charles H. Chevalier	L2C
Christine A. Gaddis	L1B
Cravath Swaine & Moore LLP	L2C
Evan R. Chesler	L5B
David Greenwald	L4A
Tatiana N. Alyonycheva	L4C
David R. Marriott	L4D
James E. Canning	L3B

Defendant

Party

Name	Ratings
Actavis Laboratories FL Inc	L5E
Actavis LLC	L5E
Andrx Corp	L5E
Actavis Inc	L5E
Actavis Pharma Inc	L3E

Attorney

Name	Ratings
Goodwin Procter LLP	L4D
Elizabeth J. Holland	L5E
Huiya Wu	L5E
Robert Cerwinski	L4B
Jonathan A. Auerbach	L4B
Shaobo Zhu	L4D
Eric Romeo	L4E
Laurel A. Kilgour	L3C
Linnea Cipriano	L3E
Connell Foley LLPLocal	L3A
Liza M. Walsh	L4A
Tricia B. O'Reilly	L2C
Walsh Pizzi Oreilly Falanga LLPLocal	L2B
Selina M. Ellis	L1B
Willkie Farr & Gallagher LLP	L2D
Eugene L. Chang	L5A